Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen R Chen

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Pediatric Blood & Cancer|March 19, 2016
Persistent Multiyear Control of Relapsed T-Cell Acute Lymphoblastic Leukemia With Successive Donor Lymphocyte Infusions: A Case ReportJeffrey S Huo, Heather J Symons, Nancy Robey, et al.
Blood|February 18, 2006
The antiapoptotic gene A1/BFL1 is a WT1 target gene that mediates granulocytic differentiation and resistance to chemotherapyLesley A Simpson, Emily A Burwell, Kida A Thompson, et al.
Pediatrics|June 18, 2016
Improved Behavior and Neuropsychological Function in Children With ROHHAD After High-Dose CyclophosphamideLisa A Jacobson, Shruti Rane, Lisa J McReynolds, et al.
Cold Spring Harbor Molecular Case Studies|July 2, 2021
Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed <i>ALK</i> F1174L-mutated neuroblastomaTingting Liu, Matthew D Merguerian, Steven P Rowe, et al.
Journal of Pediatric Hematology/Oncology|July 9, 2003
Pentostatin for the treatment of chronic graft-versus-host disease in childrenJenna D Goldberg, David A Jacobsohn, Jeffrey Margolis, et al.
Pediatric Blood & Cancer|February 24, 2007
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphomaKirsten M Williams, Meghan A Higman, Allen R Chen, et al.
Joint Commission Journal on Quality and Patient Safety|September 3, 2013
Bringing central line-associated bloodstream infection prevention home: CLABSI definitions and prevention policies in home health care agenciesMichael L Rinke, David G Bundy, Aaron M Milstone, et al.
Journal of Patient Safety|August 19, 2022
The Impact of Electronic Communication of Medication Discontinuation (CancelRx) on Medication Safety: A Pilot StudySamantha I Pitts, Yushi Yang, Taylor Woodroof, et al.
Archives of Pediatrics & Adolescent Medicine|May 3, 2006
Error reduction in pediatric chemotherapy: computerized order entry and failure modes and effects analysisGeorge R Kim, Allen R Chen, Robert J Arceci, et al.
Journal of Pediatric Hematology/Oncology|October 6, 2009
A clinical algorithm identifies high risk pediatric oncology and bone marrow transplant patients likely to benefit from treatment of adenoviral infectionKirsten Marie Williams, Allison L Agwu, Alix A Dabb, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Pediatric Blood & Cancer|March 19, 2016
Persistent Multiyear Control of Relapsed T-Cell Acute Lymphoblastic Leukemia With Successive Donor Lymphocyte Infusions: A Case ReportJeffrey S Huo, Heather J Symons, Nancy Robey, et al.
Blood|February 18, 2006
The antiapoptotic gene A1/BFL1 is a WT1 target gene that mediates granulocytic differentiation and resistance to chemotherapyLesley A Simpson, Emily A Burwell, Kida A Thompson, et al.
Pediatrics|June 18, 2016
Improved Behavior and Neuropsychological Function in Children With ROHHAD After High-Dose CyclophosphamideLisa A Jacobson, Shruti Rane, Lisa J McReynolds, et al.
Cold Spring Harbor Molecular Case Studies|July 2, 2021
Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed <i>ALK</i> F1174L-mutated neuroblastomaTingting Liu, Matthew D Merguerian, Steven P Rowe, et al.
Journal of Pediatric Hematology/Oncology|July 9, 2003
Pentostatin for the treatment of chronic graft-versus-host disease in childrenJenna D Goldberg, David A Jacobsohn, Jeffrey Margolis, et al.
Pediatric Blood & Cancer|February 24, 2007
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphomaKirsten M Williams, Meghan A Higman, Allen R Chen, et al.
Joint Commission Journal on Quality and Patient Safety|September 3, 2013
Bringing central line-associated bloodstream infection prevention home: CLABSI definitions and prevention policies in home health care agenciesMichael L Rinke, David G Bundy, Aaron M Milstone, et al.
Journal of Patient Safety|August 19, 2022
The Impact of Electronic Communication of Medication Discontinuation (CancelRx) on Medication Safety: A Pilot StudySamantha I Pitts, Yushi Yang, Taylor Woodroof, et al.
Archives of Pediatrics & Adolescent Medicine|May 3, 2006
Error reduction in pediatric chemotherapy: computerized order entry and failure modes and effects analysisGeorge R Kim, Allen R Chen, Robert J Arceci, et al.
Journal of Pediatric Hematology/Oncology|October 6, 2009
A clinical algorithm identifies high risk pediatric oncology and bone marrow transplant patients likely to benefit from treatment of adenoviral infectionKirsten Marie Williams, Allison L Agwu, Alix A Dabb, et al.
Pageof 6